USPTO serial 79412876
RAYMED
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- ALBANO, ASHLEY C
- Law office
- TMEG LAW OFFICE 105
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with RAYMED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer D. Silverman
Jennifer D. Silverman Jennifer Silverman PLLC348 West 57th StreetSuite 331New York, NY 10019Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable data processing software for graphic representations; downloadable computer programs and software for image processing; downloadable computer software for diagnosing diseases for medical purposes; downloadable software for dosimetry purposes in the field of radiotherapy and radiopharmaceutical therapy; downloadable database management computer software applications; downloadable data processing software for processing information, data, sound or images; downloadable computer software for radiation treatment planning; downloadable computer software for drug treatment planning; downloadable computer software for determining radiopharmaceutical treatment dose using artificial intelligence; downloadable computer software for calculating effective dose of medication; downloadable computer software for processing medical data. | ACTIVE | — |
| 010 | Instruments for medical use in radiotherapy and radiopharmaceutical therapy, namely for patient-specific dosimetry, radiation dose verification, and therapy planning; radiological apparatus for medical purposes; apparatus for radiotherapy and radiopharmaceutical therapy; linear accelerators for medical use in radiotherapy; medical instruments for therapeutic drug monitoring; radioisotope therapy apparatus and instruments; Test equipment for medical use, namely, apparatus and devices for measuring, monitoring, calibrating, testing, and validating radiation exposure and related parameters, namely, dose, dose distribution, dose rate, exposure time, pulses, and biological effect indicators used in radiotherapy and radiopharmaceutical therapy, namely, radiation dose calibrators, quality assurance phantoms, ionization chambers, thermoluminescent dosimeters, survey meters and downloadable software for radiation dose calculation and verification used therewith and sold as a unit; medical diagnostic imaging apparatus; diagnostic apparatus for medical purposes used in medical laboratories for diagnostic testing in oncology; telemetry apparatus for medical purposes; diagnostic measuring apparatus for medical use, namely devices for patient-specific dosimetry to aid in cancer treatment planning; magnetic field generators for medical use. | ACTIVE | — |
| 035 | Wholesale store services data featuring processing software for graphic representations; retail store services data featuring processing software for graphic representations; business intermediary services, namely, facilitating and arranging of contracts for the purchase and sale of data processing software for graphic representations; wholesale store services featuring software for dosimetry purposes in the field of radiotherapy and radiopharmaceutical therapy; retail store services featuring software for dosimetry purposes in the field of radiotherapy and radiopharmaceutical therapy; purchasing agency services, namely, purchase advisory and consulting services for software for dosimetry purposes in the field of radiotherapy and radiopharmaceutical therapy; sales agency services, namely, business intermediary services relating to the matching of buyers and sellers of software for dosimetry purposes in the field of radiotherapy and radiopharmaceutical therapy; sales arranging, namely business intermediary services relating to the matching of buyers and sellers of software for dosimetry purposes in the field of radiotherapy and radiopharmaceutical therapy; wholesale store services featuring medical devices for dosimetry purposes in the field of radiotherapy and radiopharmaceutical therapy; retail store services featuring medical devices for dosimetry purposes in the field of radiotherapy and radiopharmaceutical therapy; business intermediary services relating to the purchase and sale of medical devices, namely, the facilitation and arranging of contracts for dosimetry purposes in the field of radiotherapy and radiopharmaceutical therapy; wholesale store services featuring radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; retail store services featuring radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; business intermediary services relating to the purchase and sale of radiation measuring apparatus, namely, the facilitation and arranging of buying and selling contracts for third parties; business intermediary services relating to the purchase and sale of radiological apparatus for medical purposes, namely, the facilitation and arranging of buying and selling contracts for third parties; business intermediary services, namely, the facilitation and arranging of contracts relating to the purchase and sale of medical apparatus for the application of laser radiation for third parties; purchasing agency services for medical devices, namely, business intermediary services relating to the matching of buyers and sellers for dosimetry purposes in the field of radiotherapy and radiopharmaceutical therapy; sales agency services for medical devices, namely, business intermediary services relating to the matching of buyers and sellers for dosimetry purposes in the field of radiotherapy and radiopharmaceutical therapy; sales arranging of medical devices for dosimetry purposes in the field of radiotherapy and radiopharmaceutical therapy; purchasing agency services, namely, business intermediary services relating to the matching of buyers and sellers of radiotherapy and radiopharmaceutical therapy instruments for medical use. | ACTIVE | — |
| 042 | Computer programming in the medical field; maintenance and consultancy services relating to computer software for use in management assistance services for medical image data; development of computer software for use with medical equipment; computer programming services for remote data management of medical diagnostic instruments; technological and scientific remote monitoring services relating to medical diagnostic devices, namely, monitoring of medical diagnostic computer systems by remote access to ensure proper functioning; development agency in the nature of developing medical digital imaging device engine software; development of computer software technology in the field of computer software for medical diagnosis. | ACTIVE | — |
| 044 | Medical consultancy for selecting appropriate medicines; rental of equipment for medical purposes; remote monitoring of medical data for medical diagnosis and treatment, medical information; medical services in the field of radiology and nuclear medicine; medical analysis services for the diagnosis of cancer; medical diagnostic services in the nature of testing and analysis for medical diagnostic purposes; medical testing services relating to the diagnosis and treatment of disease; providing information in the field of cancer prevention, screening, diagnosis and treatment; medical analysis for the diagnosis and treatment of persons. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 4, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 18, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 18, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 11, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 11, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 11, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 5, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 5, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 5, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 5, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 5, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 5, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 27, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 10, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 10, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 5, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 4, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 26, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 20, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 20, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 19, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |